A New Method of preventing Adhesions. The Use of Amnioplastin after Craniotomy.
作者信息
Chao Y C, Humphreys S, Penfield W
出版信息
Br Med J. 1940 Mar 30;1(4134):517-538.1. doi: 10.1136/bmj.1.4134.517.
Abstract
摘要
相似文献
1
A New Method of preventing Adhesions. The Use of Amnioplastin after Craniotomy.
Br Med J. 1940 Mar 30;1(4134):517-538.1. doi: 10.1136/bmj.1.4134.517.
2
Clinical use of amnioplastin.
Chin Med J. 1966 May;85(5):291-301.
3
The uses of amnioplastín.
Ir J Med Sci. 1946 Mar:101-4.
4
Amnioplastin: new reagent for coagulation tests.
Lancet. 1977 Jul 30;2(8031):251. doi: 10.1016/s0140-6736(77)92871-9.
5
[Effectiveness of antiadhesion barriers in preventing adhesion for external decompression and subsequent cranioplasty].
No Shinkei Geka. 2007 Feb;35(2):151-4.
6
Treatment of Peripheral Nerve Injuries with Amnioplastin.
Br Med J. 1941 Apr 19;1(4189):587-9. doi: 10.1136/bmj.1.4189.587.
7
Amnioplastin: A Warning.
Br Med J. 1940 Nov 16;2(4167):668. doi: 10.1136/bmj.2.4167.668.
8
Efficacy of placing a thin layer of gelatin sponge over the subdural space during dural closure in preventing meningo-cerebral adhesion.
World Neurosurg. 2015 Jan;83(1):93-101. doi: 10.1016/j.wneu.2014.02.032. Epub 2014 Feb 19.
9
Use of Spongostan™ for Prevention of Cranial Subdural Adhesions Following Craniotomy in an Experimental Rabbit Model.
Turk Neurosurg. 2015;25(5):707-11. doi: 10.5137/1019-5149.JTN.10891-14.1.
10
Histological examination of expanded polytetrafluoroethylene artificial dura mater at 14 years after craniotomy: case report.
Neurol Med Chir (Tokyo). 2013;53(1):43-6. doi: 10.2176/nmc.53.43.
引用本文的文献
1
Efficacy of xenogeneic fresh and lyophilized amniotic membranes on the healing of experimentally induced full-thickness skin wounds in dogs.
Sci Rep. 2025 May 4;15(1):15605. doi: 10.1038/s41598-025-95023-9.
2
Procurement, Processing, and Storage of Human Amniotic Membranes for Implantation Purposes in Non-Healing Pressure Ulcers.
Methods Protoc. 2025 Feb 1;8(1):12. doi: 10.3390/mps8010012.
3
Human birth tissue products as a non-opioid medicine to inhibit post-surgical pain.
Elife. 2024 Dec 13;13:RP101269. doi: 10.7554/eLife.101269.
4
Human birth tissue products as a non-opioid medicine to inhibit post-surgical pain.
bioRxiv. 2024 Sep 19:2024.05.19.594874. doi: 10.1101/2024.05.19.594874.
5
The Preparation and Clinical Efficacy of Amnion-Derived Membranes: A Review.
J Funct Biomater. 2023 Oct 20;14(10):531. doi: 10.3390/jfb14100531.
6
Biological importance of human amniotic membrane in tissue engineering and regenerative medicine.
Mater Today Bio. 2023 Sep 1;22:100790. doi: 10.1016/j.mtbio.2023.100790. eCollection 2023 Oct.
7
Applications of the amniotic membrane in tissue engineering and regeneration: the hundred-year challenge.
Stem Cell Res Ther. 2022 Jan 10;13(1):8. doi: 10.1186/s13287-021-02684-0.
8
Amnion membrane improves results in treating neurogenic thoracic outlet syndrome.
J Vasc Surg Cases Innov Tech. 2018 Apr 30;4(2):163-165. doi: 10.1016/j.jvscit.2018.02.012. eCollection 2018 Jun.
9
Concise Review: Altered Versus Unaltered Amniotic Membrane as a Substrate for Limbal Epithelial Cells.
Stem Cells Transl Med. 2018 May;7(5):415-427. doi: 10.1002/sctm.17-0257. Epub 2018 Mar 23.
10
The Long Path of Human Placenta, and Its Derivatives, in Regenerative Medicine.
Front Bioeng Biotechnol. 2015 Oct 19;3:162. doi: 10.3389/fbioe.2015.00162. eCollection 2015.
Zotero 插件